Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · TARSONS

TARSONS

HealthcareHealthcare Equipment & Supplies₹1585 cr market cap
₹303.70 ▲ +1.84% today As of 19 Nov 2026
52-week low ₹166.4652-week high ₹361.50

-17.5% from the 52-week high · +79.1% above the low

Tarsons Products Ltd. engages in the production and supply of laboratory plastic ware for use within molecular biology, cell culture, genomics, proteomics and immunology. The company is headquartered in Kolkata, West Bengal and currently employs 556 full-time employees. The company went IPO on 2021-11-26. The firm is engaged in designing, development, manufacturing and marketing of consumables, reusables and others including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies contract research organizations (CROs), diagnostic companies and hospitals. The firm is also engaged in the manufacturing of range a of labware products which helps scientific discovery and improve healthcare. The firm has developed a diverse range of labware products under the categories: consumables, reusables and others. The Company’s consumables products include pipette tips, centrifuge ware, petri dishes, cryo ware and storage vials. Its reusable products include bottles and carboys, beakers, cylinders and racks. Its other products include centrifuge, vortex and pipettors.

The short version. TARSONS reported revenue of ₹124 crore for Sep 2026, up 21.6% from a year earlier. Net profit was ₹0 crore (down 100.0% year on year). Return on equity was 2.3% in Mar 2026. Promoter holding was 47.3% in Sep 2026, down 0.01 points over 8 quarters.

1 · The price

How has the stock traded?

TARSONS trades 17.5% below its 52-week high and 79.1% above its 52-week low.

Change over period: —

1M-5.4%
3M-13.1%
6M+40.2%
1Y+29.5%

2 · The business

Is it growing?

Sales, year on year+21.6%

Sep 2026 revenue of ₹124 cr.

Net margin-0.3%

3.5 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1241101211081029111396
Net profit0-14532105
Net margin %-0.3-1.33.54.73.22.09.15.5
EPS (₹)-0.06-0.270.790.950.620.341.920.99

Annual

FY2026FY2025FY2024FY2022
Revenue423392296301
Net profit143043101
Net margin %3.47.614.433.5
EPS (₹)2.695.68.0118.92

3 · The quality

How well does it turn capital into profit?

Return on equity was 2.3% in Mar 2026; debt to equity is 0.60.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %2.34.77.0—
Return on capital %4.87.19.3—
EBITDA margin %31.631.036.1—
Net margin %3.27.313.9—

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.60
Interest cover2.0x
Current ratio1.01

4 · The owners

Who holds it, and are they adding?

Promoter holding47.3%

Down 0.01 pts over 8 quarters.

Foreign institutions0.55%

Down 6.96 pts over 8 quarters.

Domestic institutions0.61%

Up 0.11 pts over 8 quarters.

Mutual fund schemes2

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter47.3147.3147.3147.3147.347.347.347.3-0.01
FII7.519.529.145.822.470.870.160.55-6.96
DII0.50.290.040.0800.190.10.61+0.11
Public44.6842.8843.5246.7850.2351.6452.4451.53+6.85

Mutual fund holdings · Oct 2026

2 schemes hold this stock

2 the month before.

  • Motilal Oswal BSE Healthcare ETF0.03% of NAV
  • Bandhan BSE Healthcare Index Fund0.03% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for TARSONS are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about TARSONS

What is the TARSONS share price?

TARSONS (TARSONS) last closed at ₹303.70, up 1.84% on the day. Its 52-week range is ₹166.46 to ₹361.50.

What is the market cap of TARSONS?

TARSONS has a market capitalisation of about ₹1,585 crore.

How are TARSONS's latest results?

TARSONS reported revenue of ₹124 crore for Sep 2026, up 21.6% from a year earlier. Net profit was ₹0 crore (down 100.0% year on year). Return on equity was 2.3% in Mar 2026. Promoter holding was 47.3% in Sep 2026, down 0.01 points over 8 quarters.

Who owns TARSONS?

As of Sep 2026, shareholding was: Promoter 47.3%, FII 0.55%, DII 0.61%, Public 51.53%.

How many mutual funds hold TARSONS?

2 mutual fund schemes held TARSONS in October 2026. That compares with 2 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 20 Sep 2024 · Final Dividend - Rs. 2

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.